International Clinical Trial: A multicenter, open-label, single-arm Phase IIa clinical trial evaluating the efficacy and safety of Ciklentanilic acid (CKBA) cream in the treatment of papulopustular rosacea

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119496) titled 'A multicenter, open-label, single-arm Phase IIa clinical trial evaluating the efficacy and safety of Ciklentanilic acid (CKBA) cream in the treatment of papulopustular rosacea' on Feb. 27.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital, Sichuan University

Condition: Papulopustular rosacea

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-03-04

Target Sample Size: 1.5% CKBA cream group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306725

Published by HT Digital Content Se...